Our findings showing enhanced ACE2 in experimental compensated CHF is in line with previous studies showing its enhanced myocardial expression in patients with CHF8, 16, 20, 25 that may represent a cardioprotective compensatory response aimed at reducing or preventing cardiac remodelling.17 This evidence concerns the gene ACE2 and congestive heart failure.